Literature DB >> 10652277

Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.

M Kieslinger1, I Woldman, R Moriggl, J Hofmann, J C Marine, J N Ihle, H Beug, T Decker.   

Abstract

Stat5 is activated by multiple receptors of hematopoietic cytokines. To study its role during hematopoiesis, we have generated primary chicken myeloblasts expressing different dominant-negative (dn) alleles of Stat5. This caused a striking inability to generate mature cells, due to massive apoptosis during differentiation. Bcl-2 was able to rescue differentiating cells expressing dnStat5 from apoptosis, suggesting that during cytokine-dependent differentiation the main function of the protein is to ensure cell survival. Our findings with dnStat5-expressing chicken myeloblasts were confirmed with primary hematopoietic cells from Stat5a/Stat5b-deficient mice. Bone marrow cells from these animals displayed a strong increase in apoptotic cell death during GM-CSF-dependent functional maturation in vitro. The antiapoptotic protein Bcl-x was induced by GM-CSF and IL-3 in a Stat5-dependent fashion. Ectopic expression of Bcl-x rescued Stat5-deficient bone marrow cells from apoptosis, indicating that Stat5 promotes the survival of myeloid progenitor cells through its ability to induce transcription of the bcl-x gene. Finally, the recruitment of myeloid cells to inflammatory sites was found strongly impeded in Stat5-deficient mice. Taken together, our findings suggest that Stat5 may promote cytokine-dependent survival and proliferation of differentiating myeloid progenitor cells in stress or pathological situations, such as inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652277      PMCID: PMC316353     

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  55 in total

1.  Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.

Authors:  C T Quang; O Wessely; M Pironin; H Beug; J Ghysdael
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

Review 2.  Growth and differentiation in the hemopoietic system.

Authors:  T M Dexter; E Spooncer
Journal:  Annu Rev Cell Biol       Date:  1987

3.  Ts mutants of E26 leukemia virus allow transformed myeloblasts, but not erythroblasts or fibroblasts, to differentiate at the nonpermissive temperature.

Authors:  H Beug; A Leutz; P Kahn; T Graf
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

Review 4.  Interleukin-3 and hematopoiesis.

Authors:  J N Ihle
Journal:  Chem Immunol       Date:  1992

Review 5.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

6.  Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

Authors:  E Stanley; G J Lieschke; D Grail; D Metcalf; G Hodgson; J A Gall; D W Maher; J Cebon; V Sinickas; A R Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.

Authors:  G Dranoff; A D Crawford; M Sadelain; B Ream; A Rashid; R T Bronson; G R Dickersin; C J Bachurski; E L Mark; J A Whitsett
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

8.  A factor induced by differentiation signals in cells of the macrophage lineage binds to the gamma interferon activation site.

Authors:  A Eilers; M Baccarini; F Horn; R A Hipskind; C Schindler; T Decker
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

9.  Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease.

Authors:  G J Lieschke; E Stanley; D Grail; G Hodgson; V Sinickas; J A Gall; R A Sinclair; A R Dunn
Journal:  Blood       Date:  1994-07-01       Impact factor: 22.113

10.  Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response.

Authors:  H Wakao; F Gouilleux; B Groner
Journal:  EMBO J       Date:  1994-05-01       Impact factor: 11.598

View more
  52 in total

Review 1.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

Review 2.  Crossing paths: interactions between the cell death machinery and growth factor survival signals.

Authors:  Gabriela Brumatti; Marika Salmanidis; Paul G Ekert
Journal:  Cell Mol Life Sci       Date:  2010-02-16       Impact factor: 9.261

3.  The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.

Authors:  Agata Klejman; Steven J Schreiner; Malgorzata Nieborowska-Skorska; Artur Slupianek; Matthew Wilson; Thomas E Smithgall; Tomasz Skorski
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

4.  Transcription elongation factor S-II is required for definitive hematopoiesis.

Authors:  Takahiro Ito; Nagisa Arimitsu; Masaki Takeuchi; Nobuyuki Kawamura; Makiko Nagata; Kayoko Saso; Nobuyoshi Akimitsu; Hiroshi Hamamoto; Shunji Natori; Atsushi Miyajima; Kazuhisa Sekimizu
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

5.  Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis.

Authors:  Mario Skarica; Tianhong Wang; Erin McCadden; David Kardian; Peter A Calabresi; Donald Small; Katharine A Whartenby
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

6.  Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.

Authors:  Wei Tong; Harvey F Lodish
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

7.  The transcription factors STAT5A/B regulate GM-CSF-mediated granulopoiesis.

Authors:  Akiko Kimura; Michael A Rieger; James M Simone; Weiping Chen; Mark C Wickre; Bing-Mei Zhu; Philipp S Hoppe; John J O'Shea; Timm Schroeder; Lothar Hennighausen
Journal:  Blood       Date:  2009-09-24       Impact factor: 22.113

8.  Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia.

Authors:  Andrea Hoelbl; Christian Schuster; Boris Kovacic; Bingmei Zhu; Mark Wickre; Maria A Hoelzl; Sabine Fajmann; Florian Grebien; Wolfgang Warsch; Gabriele Stengl; Lothar Hennighausen; Valeria Poli; Hartmut Beug; Richard Moriggl; Veronika Sexl
Journal:  EMBO Mol Med       Date:  2010-03       Impact factor: 12.137

9.  Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development.

Authors:  Stephen Malin; Shane McManus; César Cobaleda; Maria Novatchkova; Alessio Delogu; Philippe Bouillet; Andreas Strasser; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

10.  Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses.

Authors:  Lina Han; Albertus T J Wierenga; Marjan Rozenveld-Geugien; Kim van de Lande; Edo Vellenga; Jan Jacob Schuringa
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.